Retatrutide & AOD9604: A Deep Dive into the "Triple Plus" Protocol We know that Retatrutide is the new heavy hitter on the block, but when you add AOD9604 to the mix, you aren't AOD 9604 5mg Pura Peptides AOD 9604 vs. Semaglutide Hormone Replacement Therapy AOD 9604 had six human trials and 900 participants. Phase IIa showed positive results. Then the pivotal Phase IIb failed at every dose tested. Development was terminated in 2007. The trial history is Important Update on FDA Changes Concerning Peptides FDA Peptide Category Update: Clarifying Misinformation Cole Thomas posted on the topic LinkedIn